MRC1 and colorectal carcinoma: In 2009 The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group recommended universal screening, stating that all newly diagnosed CRC patients should undergo testing for MSI or IHC of MMR proteins, with follow-up germline testing to be performed on MSI or MMR deficient (dMMR) tumors22,23.